Prelude Therapeutics (PRLD) Stock Price, Quote, News & History | Benzinga

SPY774.46+0.07%QQQ747.75+0.02%BTC/USD81,904.31+0.26%DIA511.79+0.03%GLD379.46+0.22%TLT77.66−0.27%

Prelude Therapeutics Inc (PRLD) Stock Price, Quote, News & History

PRLDNASDAQ

Trade with Public

Trade with Public

$3.88

0.051.31%

Last update: Oct 8, 7:39 PM

$3.82

-0.01-0.26%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.77

Close

$3.88

Volume / Avg.

424.10K / 472.46K

Day Range

$3.66 - $3.95

52 Wk Range

1.15 - 6.83

Market Cap

$304.85M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

14.33%

Days to Cover

9

Recent Prelude Therapeutics Incorporated News

Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.

Avi Kapoor

Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up 0.1%, Dave and Buster's (PLAY) down 13.4% pre-market due to lower earnings; other stocks declining in pre-market trading

Avi Kapoor

Seagate To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Monday

Wall Street analysts changed their outlook on top companies. Truist Securities, Guggenheim, Benchmark, HC Wainwright, Stifel, B of A Sec, Mizuho updated their ratings and price targets.

Avi Kapoor

Dow Dips Over 400 Points; Pfizer Earnings Top Estimates

Avi Kapoor

Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-33.26M

Investing Cash Flow (TTM)

-77.25M

Financing Cash Flow (TTM)

110.45M

Free Cash Flow (TTM)

-33.26M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-62.00K

Analyst Trends and Forecast

1

Apr

1

May

1

Jul

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$170.74M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

14.35

PB Ratio (TTM)

2.28

Earnings Yield % (TTM)

-19.11%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.68

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$26.33M

Debt to Equity

0.13

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0